Gene hunt aims to prevent antidepressant agitation in youth

NCT ID NCT06763081

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study aims to find genetic markers that can predict which children and youth (ages 6-24) with depression, anxiety, or OCD may experience behavioral activation—a side effect like agitation or restlessness—when taking SSRI antidepressants. Researchers will analyze DNA from 160 participants in Manitoba to compare those who had this side effect with those who did not. The goal is to develop a genetic test that helps doctors choose safer treatments for young patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANXIETY DISORDERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Shared Health Facilities

    RECRUITING

    Winnipeg, Manitoba, R3C 3H8, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • University of Manitoba College of Pharmacy

    RECRUITING

    Winnipeg, Manitoba, R3E 0T5, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.